RNA Polymerase and Transcription Initiation

RNA polymerases are the DNA-dependent enzymes that synthesise RNA from a DNA template, and transcription initiation is the rate-limiting first phase in which the enzyme locates a promoter, unwinds the DNA and begins making RNA. Because initiation is where most regulation converges, the structure of the polymerase and the steps that commit it to a gene are central to understanding gene expression.

Definition

DNA-directed RNA polymerases are enzymes that catalyse template-directed synthesis of RNA from ribonucleoside triphosphates; transcription initiation is the set of steps from promoter binding through open-complex formation to the synthesis of the first phosphodiester bonds and escape into elongation.

Scope

The topic covers the catalytic RNA polymerase enzyme and the events of initiation: promoter recognition (in bacteria via sigma factors, in eukaryotes via general transcription factors), open-complex formation, abortive initiation and promoter escape into productive elongation. It treats the enzyme and its first commitment step mechanistically and is reference-educational, not clinical guidance.

Core questions

• How does RNA polymerase recognise a promoter and position its active site at the start site?
• What converts a closed promoter complex into a transcription-competent open complex?
• Why is promoter escape a distinct, often rate-limiting, step?

Key concepts

• Core enzyme and holoenzyme
• Sigma factor (bacterial) and general transcription factors (eukaryotic)
• Closed and open promoter complexes
• Abortive initiation
• Promoter escape
• Two-metal-ion catalysis at the active site

Mechanisms

Initiation begins when RNA polymerase, guided by a specificity factor, binds promoter DNA to form a closed complex; local unwinding then produces an open complex that exposes the template strand in the active-site cleft. The enzyme synthesises short RNAs in repeated abortive cycles before escaping the promoter and releasing its initiation factor to enter processive elongation. High-resolution structures of RNA polymerase II showed the conserved active-site architecture and clamp that underlie these transitions, and single-molecule and nascent-RNA studies revealed that initiation factor retention and post-initiation pausing are widespread features of the transition from initiation to elongation.

Clinical relevance

RNA polymerases are targets of clinically important antibiotics and toxins (for example, agents acting on bacterial polymerase, and amatoxins acting on eukaryotic Pol II), and altered initiation contributes to disease gene programmes. This entry describes the enzymology at a reference level and does not provide treatment guidance.

History

The discovery that eukaryotes contain multiple DNA-dependent RNA polymerases (Roeder and Rutter, 1969) distinguished the enzymes that initiate transcription of different gene classes. The 2001 atomic structure of RNA polymerase II by Cramer, Bushnell and Kornberg gave a mechanistic picture of the catalytic machine, and genome-scale nascent-RNA methods later reshowed initiation as a dynamic, frequently paused step.

Key figures

• Robert G. Roeder
• Roger Kornberg
• Patrick Cramer
• Richard H. Ebright

Seminal works

• roeder-rutter-1969
• cramer-2001

Frequently asked questions

What is the difference between the core enzyme and the holoenzyme?

The core enzyme has the catalytic activity to make RNA, while the holoenzyme adds an initiation specificity factor (such as bacterial sigma) that lets it recognise promoters and start transcription at the correct site.

Why is promoter escape considered a separate step?

After making the first short RNA, polymerase often releases and re-makes abortive products before it breaks contacts with the promoter and commits to processive elongation, so escape is a distinct, regulated transition.